Nuvalent’s Establishment and Prosecution of Global Patent Portfolios

Jones Day advised Nuvalent on the deal.Nuvalent, Inc. announced the establishment and prosecution of global patent portfolios related to small molecule ROS1-selective inhibitors, ALK-selective inhibitors, and HER2-selective…

This content is for members only.
Login to Read More Join Now
Martina Bellini

Author: Martina Bellini

This content is for members only.
Login to Read More Join Now